药物受理最新动态：Vertex Pharmaceuticals IncorporatedALP...

Core Viewpoint - Vertex Pharmaceuticals Incorporated's ALPN-303 injection application has been accepted for review by the National Medical Products Administration, indicating progress in the company's drug development pipeline [1] Group 1: Application Details - The application for ALPN-303 injection was accepted on January 6, 2026, with the acceptance number JXSB2600003 [1] - ALPN-303 is classified as a therapeutic biological product and is categorized under a supplemental application registration [1] - The companies involved in the application include Vertex Pharmaceuticals Incorporated, Vetter Development Services USA Inc., and Vetter Pharma-Fertigung GmbH & Co. KG [1]